Cargando…
Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interactio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138798/ https://www.ncbi.nlm.nih.gov/pubmed/35625823 http://dx.doi.org/10.3390/biomedicines10051086 |
_version_ | 1784714708435075072 |
---|---|
author | Tokajuk, Joanna Deptuła, Piotr Piktel, Ewelina Daniluk, Tamara Chmielewska, Sylwia Wollny, Tomasz Wolak, Przemysław Fiedoruk, Krzysztof Bucki, Robert |
author_facet | Tokajuk, Joanna Deptuła, Piotr Piktel, Ewelina Daniluk, Tamara Chmielewska, Sylwia Wollny, Tomasz Wolak, Przemysław Fiedoruk, Krzysztof Bucki, Robert |
author_sort | Tokajuk, Joanna |
collection | PubMed |
description | The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome. |
format | Online Article Text |
id | pubmed-9138798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91387982022-05-28 Cathelicidin LL-37 in Health and Diseases of the Oral Cavity Tokajuk, Joanna Deptuła, Piotr Piktel, Ewelina Daniluk, Tamara Chmielewska, Sylwia Wollny, Tomasz Wolak, Przemysław Fiedoruk, Krzysztof Bucki, Robert Biomedicines Review The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome. MDPI 2022-05-07 /pmc/articles/PMC9138798/ /pubmed/35625823 http://dx.doi.org/10.3390/biomedicines10051086 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tokajuk, Joanna Deptuła, Piotr Piktel, Ewelina Daniluk, Tamara Chmielewska, Sylwia Wollny, Tomasz Wolak, Przemysław Fiedoruk, Krzysztof Bucki, Robert Cathelicidin LL-37 in Health and Diseases of the Oral Cavity |
title | Cathelicidin LL-37 in Health and Diseases of the Oral Cavity |
title_full | Cathelicidin LL-37 in Health and Diseases of the Oral Cavity |
title_fullStr | Cathelicidin LL-37 in Health and Diseases of the Oral Cavity |
title_full_unstemmed | Cathelicidin LL-37 in Health and Diseases of the Oral Cavity |
title_short | Cathelicidin LL-37 in Health and Diseases of the Oral Cavity |
title_sort | cathelicidin ll-37 in health and diseases of the oral cavity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138798/ https://www.ncbi.nlm.nih.gov/pubmed/35625823 http://dx.doi.org/10.3390/biomedicines10051086 |
work_keys_str_mv | AT tokajukjoanna cathelicidinll37inhealthanddiseasesoftheoralcavity AT deptułapiotr cathelicidinll37inhealthanddiseasesoftheoralcavity AT piktelewelina cathelicidinll37inhealthanddiseasesoftheoralcavity AT daniluktamara cathelicidinll37inhealthanddiseasesoftheoralcavity AT chmielewskasylwia cathelicidinll37inhealthanddiseasesoftheoralcavity AT wollnytomasz cathelicidinll37inhealthanddiseasesoftheoralcavity AT wolakprzemysław cathelicidinll37inhealthanddiseasesoftheoralcavity AT fiedorukkrzysztof cathelicidinll37inhealthanddiseasesoftheoralcavity AT buckirobert cathelicidinll37inhealthanddiseasesoftheoralcavity |